Cancer in remission — when health cover becomes possible again
Bishan Kumar Agarwal
The standard market line is “post-cancer, no fresh cover for five years.” It is repeated so often that most people — and many advisors — treat it as regulation. It is not. It is a heuristic that some insurers use for some cancers. The real answer is more specific: five years for certain high-risk or late-stage cancers; three years for several common ones; sometimes earlier for low-grade thyroid or skin cancers with strong documentation.
If you or someone in your family is in remission and has been told to wait, this article explains how underwriters actually read a post-cancer file — and what documentation changes the answer.
Which remissions get written
Insurers do not see “cancer” as one risk. They see a file: the cancer type, the stage at diagnosis, the treatment modality, the time since last evidence of disease, and the quality of follow-up documentation.
- Breast cancer (Stage I or II) in remission for three or more years: Several of the larger health insurers — including HDFC Ergo and Care Health — will write these files at 40–80% loading. The underwriting trigger is consistent follow-up imaging showing no evidence of disease, not merely the passage of time.
- Cervical cancer post-treatment, three or more years stable: Similar treatment to early-stage breast cancer. Requires documentation that treatment (surgery, radiation, or both) was complete and that there has been no recurrence.
- Thyroid cancer (papillary type, treated): Papillary thyroid cancer has a very high survival rate with surgery and radioiodine. Many underwriters will write these files within two years of treatment completion, particularly when the oncologist can document stable TSH levels and no residual disease.
- Stage IV cancers or recurring cancers: Most standard insurers decline the base plan. Some will offer a cancer-specific rider (not a base plan) — but read the sum assured. It is rarely the same number as the cover you were looking for.
The single most important variable is not the cancer type — it is whether the treating oncologist is willing to write a clear, dated “no evidence of disease” letter. Without that letter, the file does not move.
The documentation that changes the answer
Underwriters making a post-cancer decision are trying to answer one question: is this person stable? Documentation that answers that question directly is what changes the outcome.
- Oncologist's NED letter: The “no evidence of disease” letter, dated within the last three to six months, is the cornerstone. It should state the diagnosis, the treatment, the date of completion, and the current status.
- PET-CT reports: Two consecutive all-clear PET-CT scans — typically 12 months apart — provide the imaging evidence that the NED letter summarises. Submit both, with dates.
- Treatment history: A chronological summary of treatment — surgery date, chemotherapy cycles (if any), radiation (if any), hormone therapy (if ongoing). Some insurers want this as a treating-hospital summary; others accept a structured document prepared by your oncologist.
Remission is not absence. It's the absence of evidence. Underwriters understand the difference — they price the file accordingly.
Loading, sub-limits, and the catches you will miss
Getting issued a policy after a cancer history is a genuine achievement. But the policy you receive may have features that change what it actually covers — and these are worth understanding before you pay the first premium.
Premium loading
Loading is an extra premium charged to reflect the higher perceived risk. For post-cancer files, loadings of 40–80% are common. This means if the standard annual premium for your age and sum assured is ₹20,000, you might pay ₹28,000–₹36,000. The loading is not permanent in theory — but most insurers do not have a formal mechanism to reduce it based on continued remission. You can re-apply after additional disease-free years, but that requires a fresh application and a new underwriting decision.
Cancer-specific waiting period
Many plans add a cancer-specific waiting period — typically 24 months — for claims related to the original cancer or its recurrence. This is separate from the standard pre-existing disease waiting period. Read the policy schedule carefully. You may be covered for unrelated conditions from day one, but not for cancer-related admissions during the first two years.
Exclusion of cancer recurrence
Some plans explicitly exclude cancer recurrence even after the waiting period is served. This is rare but not unheard of. If you see this clause, the policy is essentially a general health plan that does not cover the one thing you are most likely to need. Walk away from that particular plan.
What to do
Do not take the first plan offered. Insurers use the same base documents (NED letter, PET-CT, treatment history) but underwrite differently. A file that one insurer writes at 80% loading, another might write at 40% — or decline entirely. Presenting the file to three or four insurers, with the same documentation, often produces meaningfully different outcomes.
Insurance is a contract between you and the insurer. This article is general information only — speak to a licensed advisor about your specific situation before making decisions.
The cancer waiting period is not the same as the PED waiting period
Many plans have a specific cancer-recurrence waiting period on top of the standard pre-existing disease wait. Read both clauses — they can stack.
Cancer rider on a base plan is not full cancer cover
A cancer rider typically covers only a defined event (e.g., diagnosis of a listed cancer stage). The sum assured on a rider is often a fraction of the base plan. Check the number.
Recurrence vs metastasis — the declaration matters
These are underwriting terms, not just medical ones. If your treating oncologist used the word ‘metastasis’ at any stage, declare it. The distinction affects how the file is read.
Follow-up PET/MRI of the original site may be excluded
Some plans exclude imaging of the original cancer site even after the waiting period, treating it as surveillance for a pre-existing condition. Check the Schedule of Benefits before assuming cover.
47-year-old female, Stage II breast cancer, in remission 5 years.
47-year-old salaried professional from Gurugram. Diagnosed with Stage II breast cancer in 2020, treated with surgery and chemotherapy, no evidence of disease on two subsequent PET-CT scans.
Had been told by two advisors that she could not get health cover until 5 years had passed. Approached us in her 5th year post-treatment, still assuming she was ineligible.
Submitted the oncologist's ‘no evidence of disease’ letter alongside two consecutive all-clear PET-CT reports and a structured treatment history. Presented to ICICI Lombard with a cover letter framing the file as stable remission.
Issued at ₹15L cover with 65% loading and a 24-month cancer-specific waiting period on recurrence. A meaningful policy — with the right documentation.
In year 2 or 3 post-treatment? It is worth the conversation.
We have placed cover for cancer patients in remission. The answer depends on the cancer type, the documentation, and which insurer you approach — not a blanket five-year rule.
WhatsApp our team · freeCommon questions.
- What counts as ‘remission’ for an insurer?
- Most underwriters require an oncologist's letter stating ‘no evidence of disease’ (NED), supported by at least one clean imaging study — typically a PET-CT. ‘Remission’ without documented imaging is harder to place. The stronger your documentation, the easier the underwriting conversation.
- Can I get cover during active treatment?
- Generally no — active treatment means the risk is current and unquantified. Most insurers require treatment to be complete and a defined disease-free period to have elapsed. A few specialist underwriters will consider it for very low-grade cancers, but these are exceptions.
- What if my cancer is hereditary (BRCA-positive)?
- A BRCA mutation in the absence of cancer is a different file from a cancer history. Some underwriters treat it as a higher-risk flag and apply loading; others write it without loading if there is no personal cancer history. It must be declared on the form. Do not leave it out.
- Does loading reduce over time as my remission lengthens?
- Not automatically. Most plans do not have a built-in loading reduction mechanism tied to remission duration. However, you can re-approach the same or a different insurer after additional disease-free years and submit fresh documentation — a new underwriting decision may result in better terms.